Microprofit - Fluorecare

This respiratory infections rapid testing portfolio provides a comprehensive range of single-sample, multi-pathogen colloidal gold immunoassay tests designed for fast, accurate, and cost-effective diagnosis of upper and lower respiratory tract infections. With results available in 12–15 minutes, CE certification, and the ability to detect up to 13 pathogens in a single test, the solution supports early differential diagnosis, treatment guidance, and large-scale screening. The portfolio includes both self-test and professional-use formats and has been validated through large-scale global deployment exceeding 110 million tests.

Please Log In to access Additional Details and documents …

• Single-pathogen antigen tests:
  Individual rapid antigen tests targeting SARS-CoV-2 for professional use with results in approximately 15 minutes.
  
  

• 3-in-1 respiratory virus combo tests:
  Combined detection of SARS-CoV-2, Influenza A, and Influenza B for rapid differentiation of common seasonal respiratory infections.
  
  

• 4-in-1 respiratory virus combo tests:
  Simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV, covering over 50% of major upper respiratory pathogens.
  
  

• 6-in-1 respiratory virus combo tests:
  Detection of SARS-CoV-2, Influenza A, Influenza B, RSV, Adenovirus, and Human Metapneumovirus for expanded viral screening.
  
  

• 8-in-1 respiratory virus combo tests:
  Broad-panel detection of SARS-CoV-2, Influenza A, Influenza B, RSV, Rhinovirus, Parainfluenza Virus, Adenovirus, and Human Metapneumovirus, covering more than 95% of common viral upper respiratory infections.
  
  

• Respiratory virus + bacteria + mycoplasma mixed combo tests (BM4 / BM5):
  Panels combining viral targets with bacterial and mycoplasma detection including Streptococcus pneumoniae, Legionella pneumophila, Staphylococcus aureus, Klebsiella pneumoniae, and Mycoplasma pneumoniae, optimized for pediatric and lower respiratory tract infections.
  
  

• 9-in-1 respiratory pathogen combo tests (VBM9):
  Combined detection of 4 viruses, 4 bacteria, and 1 mycoplasma for professional rapid comprehensive respiratory infection testing.
  
  

• 13-in-1 respiratory pathogen combo tests (VBM13):
  High-coverage panels detecting 8 viruses, 4 bacteria, and 1 mycoplasma, achieving up to 99% clinical respiratory pathogen coverage.
  
  

• Self-test and professional-use formats:
  Self-test options available in 1, 2, and 5 tests per box; professional-use formats supplied in 1, 10, or 25 tests per box.
  
  

• Clinical performance and logistics:
  High sensitivity and specificity; storage at 2–30 °C; shelf life up to 24–36 months; supports mass screening, outpatient diagnostics, emergency departments, and primary care.